Delivery Order SPE2D021DA002-SPE2D325F307J
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,146.40 for Adacel TDAP vaccine vials (0.5 mL) on August 4, 2025. The award carries an ultimate completion date of August 7, 2025 and was issued without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,821.96 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The contract calls for delivery of Adacel TDAP vaccine in 0.5mL vials to support Department of Defense healthcare facilities. This delivery order was issued without set-aside designation and carries an ultimate completion date of August 21,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order contract on April 21, 2025, for ADACEL TDAP VIAL with a ceiling value of $1,214.64. This firm fixed-price delivery order was issued by the Defense Logistics Agency under its Medical Supply Chain program without a set-aside designation. The award represents a continuation of the company's substantial involvement in federal pharmaceutical supply,...
- The U.S. Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $6,073.20 to DMS Pharmaceutical Group Inc. for the supply of Adacel TDAP vaccine vials (0.5ML). The award, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $1,906.16 firm fixed-price delivery order for tetanus/diphtheria vaccines on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract carries no set-aside designation and represents a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB program to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,219.04 delivery order is for the supply of ADACEL TDAP VIAL, with a completion date of June 20, 2024. The order is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 27, 2025, by the Defense Logistics Agency for the supply of Boostrix TDAP vaccine in 0.5 mL syringes. The contract carries a ceiling value of $17,048.40 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 28, 2025. No set-aside designation was utilized for this award, and the place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on July 11, 2025, for YF-VAX 1 dose vials valued at $8,350.65. This firm fixed-price delivery order, which carries no set-aside designation, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.9 million and valid...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $37,832.55 firm fixed-price purchase order by the Department of Defense's Medical Supply Chain on August 10, 2025, with an ultimate completion date of August 25, 2025. The contract is designated as a Total Small Business set-aside and covers the supply of Meningococcal Group vaccines and related pharmaceutical products to support federal healthcare operations. The...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,472.55, is for the delivery of ADACEL TDAP VIAL, a pharmaceutical product. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, valued at up to $499,999,999 and running...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F307JDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,518.30 on August 11, 2025, for the supply of Adacel TDAP vaccine vials (0.5ml). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, carries no set-aside designation and is being funded by the Defense Department's Medical Supply Chain. The award represents a specific issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts for an extensive portfolio of medications, biologics, and medical consumables destined for Department of Defense healthcare facilities nationwide. The company's contract history demonstrates consistent delivery of specialized pharmaceutical products ranging from vaccines and injections to oncology treatments and prescription medications, supporting military medical supply requirements across the globe. This particular delivery order for Adacel TDAP vaccine vials exemplifies the company's role in supplying routine immunization products essential to military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/11/25 |